# Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease

> **NCT03914079** · — · SUSPENDED · sponsor: **AusculSciences Canada Inc.** · enrollment: 2000 (estimated)

## Conditions studied

- Coronary Artery Disease
- Cardiovascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03914079
- **Lead sponsor:** AusculSciences Canada Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-04-05
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Why stopped:** Sponsor due to COVID-19
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914079, "Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03914079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*